General Information of Drug Transporter (DT)
DT ID DTD0353 Transporter Info
Gene Name SLC40A1
Transporter Name Iron-regulated transporter 1
Gene ID
30061
UniProt ID
Q9NP59
Post-Translational Modification of This DT
Overview of SLC40A1 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X-Polyubiquitination X-Ubiquitination X: Amino Acid

N-glycosylation

  Asparagine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC40A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

174

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC40A1 Asparagine 174 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC40A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

434

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC40A1 Asparagine 434 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC40A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

567

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC40A1 Asparagine 567 has the potential to affect its expression or activity.

Phosphorylation

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC40A1 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

419

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC40A1 Threonine 419 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC40A1 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

421

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC40A1 Threonine 421 has the potential to affect its expression or activity.

  Tyrosine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC40A1 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

20

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC40A1 Tyrosine 20 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC40A1 [4]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

302

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC40A1 Tyrosine 302 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC40A1 [4]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

303

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC40A1 Tyrosine 303 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC40A1 [4]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

538

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC40A1 Tyrosine 538 has the potential to affect its expression or activity.

Polyubiquitination

  Lysine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Decreasing the activity of SLC40A1 [5]

Role of PTM

Protein Activity Modulation

Modified Residue

Lysine

Modified Location

229

Related Enzyme

E3 ubiquitin-protein ligase RNF217 (RNF217)

Experimental Material(s)

Human embryonic kidney 293 (HEK293) cells

Experimental Method

Co-Immunoprecipitation

Detailed Description

Polyubiquitination at SLC40A1 Lysine 229 have been reported to decrease its transport activity.

  PTM Phenomenon 2

Decreasing the activity of SLC40A1 [5]

Role of PTM

Protein Activity Modulation

Modified Residue

Lysine

Modified Location

269

Related Enzyme

E3 ubiquitin-protein ligase RNF217 (RNF217)

Experimental Material(s)

Human embryonic kidney 293 (HEK293) cells

Experimental Method

Co-Immunoprecipitation

Detailed Description

Polyubiquitination at SLC40A1 Lysine 269 have been reported to decrease its transport activity.

Ubiquitination

  Lysine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC40A1 [6]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

236

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC40A1 Lysine 236 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC40A1 [7] , [8]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

247

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC40A1 Lysine 247 has the potential to affect its expression or activity.

  Phenylalanine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC40A1 [7] , [9]

Role of PTM

Potential impacts

Modified Residue

Phenylalanine

Modified Location

207

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC40A1 Phenylalanine 207 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S40A1_HUMAN)
2 Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra. J Proteome Res. 2007 Nov;6(11):4150-62.
3 Comparative N-glycoproteomic and phosphoproteomic profiling of human placental plasma membrane between normal and preeclampsia pregnancies with high-resolution mass spectrometry. PLoS One. 2013 Nov 15;8(11):e80480.
4 Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT. Cell Metab. 2012 Jun 6;15(6):905-17.
5 Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination. Cell Metab. 2012 Jun 6;15(6):918-24.
6 Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease. Proteomics. 2018 Oct;18(20):e1800108.
7 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
8 UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
9 A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.